Your search returned 65 studies. (Get alerts for new studies):
- RAD001 in Advanced Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma
3 Locations available
- Trial of Beads Versus Doxorubicin Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma - Liver Cancer - Hepatoma
1 Location available
- TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma - Liver Cancer - Liver Neoplasm - Primary Liver Cancer
1 Location available
- Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy
Conditions: Liver Cancer
1 Location available
- A Study of LY2157299 in Patients With Hepatocellular Carcinoma
Conditions: Carcinoma - Hepatocellular
6 Locations available
- The LC Bead Trial; Transarterial Chemoembolization of Hepatocellular Carcinoma (HCC)With a Drug-eluting Bead
Conditions: Hepatocellular Carcinoma
1 Location available
- Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer
Conditions: Hepatocellular Carcinoma - Liver Cancer
1 Location available
- Microwave Ablation of Resectable Liver Tumors
Conditions: Hepatocellular Carcinoma - Liver Cancer
1 Location available
- Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma
Conditions: Liver Cancer
3 Locations available
- Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myelom
Conditions: Multiple Myeloma - Diffuse Large B-Cell Lymphoma - Glioblastoma Multiforme - Hepatocellular Carcinoma - Non-Small Cell Lung Cancer - Gastrointestinal Neuroendocrine Tumors of Non-Pancreatic Origin - Hormone Receptor-Positive Breast Cancer
8 Locations available
- TRC105 for Liver Cancer That Has Not Responded to Sorafenib
Conditions: Hepatocellular Carcinoma - Hepatocellular Cancer - Carcinoma, Hepatocellular
1 Location available
- Comparing Lipiodol/Ethanol With Drug-eluting Beads (DEB) for Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma
1 Location available
- Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
Conditions: Liver Cancer
1 Location available
- Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma - Liver Cancer
1 Location available
- Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma
2 Locations available
- Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies
Conditions: Neuroendocrine Tumors - Brain (Nervous System) Cancers - Colon/Rectal Cancer - Colon Cancer - Hepatobiliary Cancers - Hepatocellular Carcinoma (Hepatoma) - Liver
1 Location available
- Humanitarian Device Exemption (HDE) Treatment Protocol
Conditions: Carcinoma, Hepatocellular - Liver Cancer
1 Location available
- Sorafenib Dose Ramp-Up in Hepatocellular Carcinoma (HCC)
Conditions: Hepatocellular Carcinoma
9 Locations available
- Sorafenib and TRC105 in Hepatocellular Cancer
Conditions: Hepatoma - Liver Neoplasms - Adenoma, Liver Cell - Carcinoma, Hepatocellular
1 Location available
- A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer
Conditions: Advanced Hepatocellular Carcinoma - HCC - Liver Cancer
1 Location available
- Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer
Conditions: Unresectable Hepatocellular Carcinoma
2 Locations available
- An Open-Label Study to Explore the Clinical Efficacy of GS 7977 With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recur
Conditions: Hepatitis C - Hepatocellular Carcinoma
1 Location available
- Temsirolimus as Second-line Therapy in HCC
Conditions: Unresectable or Metastatic Hepatocellular Carcinoma
1 Location available
- Transplant Patient Registry of Liver, Kidney and/or Pancreas
Conditions: Hepatitis B - Hepatitis C - Liver Cirrhosis - Hepatocellular Carcinoma - Polycystic Kidney Diseases
1 Location available
- A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
Conditions: Metastatic Breast Cancer - Advanced Breast Cancer - Gastrointestinal Stromal Tumor - Hepatocellular Carcinoma - Metastasizing Breast Cancer (F) - Metastatic Castration-Resistant Prostrate Cancer - Metastatic Renal Cell Cancer - Non Small Cell Lung Cancer
2 Locations available
- SBRT + TACE for Primary Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma
4 Locations available
- LC Drug Eluting Bead for Treatment of Liver Cancer Which Cannot be Surgically Removed
Conditions: Hepatocellular Carcinoma
1 Location available
- A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area
Conditions: Carcinoma, Hepatocellular - Liver Cirrhosis, Alcoholic - Hepatitis, Alcoholic - Hepatitis, Chronic - Hepatitis, Viral, Human
3 Locations available
- Safety Study of Liver Natural Killer Cell Therapy for Hepatoma Liver Transplantation
Conditions: Liver Cirrhosis - Hepatocellular Carcinoma - Liver Transplantation
1 Location available
- Effect of Sorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin
Conditions: Renal Cell Carcinoma - Hepatocellular Carcinoma
1 Location available
- Everolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular Carcinoma
Conditions: Advanced Adult Hepatocellular Carcinoma
1 Location available
- Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI
Conditions: Hepatocellular Carcinoma
1 Location available
- A Study of IMC-A12 in Combination With Sorafenib in Patients With Advanced Cancer of the Liver
Conditions: Hepatocellular Carcinoma
7 Locations available
- Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular
Conditions: Carcinoma
6 Locations available
- Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors
Conditions: Pancreatic Cancer - Liver Cancer - Lung Cancer - Lung Cancer Non-Small Cell Cancer (NSCLC) - Lung Cancer Small Cell Lung Cancer (SCLC) - Hepatobiliary Cancers - Hepatobiliary Cancers Liver - Hepatobiliary Cancers Hepatocellular Carcinoma (Hepatoma) - Hepa
1 Location available
- ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy
Conditions: Hepatocellular Carcinoma
6 Locations available
- Stereotactic Body Radiotherapy for Liver Tumors
Conditions: Liver Metastases - Hepatocellular Carcinoma - Intrahepatic Cholangiocarcinoma
1 Location available
- TheraSphere for the Treatment of Unresectable Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma
1 Location available
- The Effect of Vitamin D Repletion in Patients With Hepatocellular Carcinoma on the Orthotopic Liver Transplant List
Conditions: Vitamin D Deficiency - Hepatocellular Carcinoma
1 Location available
- Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma
Conditions: Liver Cancer
3 Locations available
- Transarterial Chemoembolization Versus Proton Beam Radiotherapy for the Treatment of Hepatocellular Carcinoma
Conditions: Carcinoma, Hepatocellular
1 Location available
- A Clinical Study of GP73 as a Hepatocellular Carcinoma (HCC) Tumor Mark
Conditions: Hepatocellular Carcinoma
1 Location available
- Siliphos in Advanced Hepatocellular Carcinoma
Conditions: Advanced Hepatocellular Carcinoma
1 Location available
- Proton Beam Radiotherapy Plus Sorafenib Versus Sorafenib for Patients With Hepatocellular Carcinoma Exceeding San Francisco Criteria
Conditions: Carcinoma, Hepatocellular
1 Location available
- A Phase II Study Using Short-Term Cultured, CD8+-Enriched Autologous Tumor-infiltrating Lymphocytes Following a Lymphocyte Depleting Regimen in Metast
Conditions: Metastatic Colorectal Cancer - Metastatic Gastric Cancer - Metastatic Pancreatic Cancer - Metastatic Hepatocellular Carcinoma - Metastatic Cholangiocarcinoma
1 Location available
- ABT-888 and Temozolomide for Liver Cancer
Conditions: Hepatocellular Carcinoma
1 Location available
- A Pilot Study of Trans Arterial Chemoembolization (TACE), Followed by Stereotactic Radiation Therapy (SBRT) for Patients With Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma (HCC)
1 Location available
- Study of Sorafenib With or Without VT-122 in Patients With Hepatocellular Carcinoma (HCC)
Conditions: Hepatocellular Carcinoma
7 Locations available
- Lenalidomide in Combination With a Fixed Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma
1 Location available
- Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
Conditions: Adult Anaplastic Astrocytoma - Adult Anaplastic Oligodendroglioma - Adult Giant Cell Glioblastoma - Adult Glioblastoma - Adult Gliosarcoma - Adult Mixed Glioma - Adult Primary Hepatocellular Carcinoma - Chondrosarcoma - Clear Cell Sarcoma of the Kidney -
1 Location available
- TheraSphere HUD For Treatment of Unresectable Hepatocellular Carcinoma (HCC)
Conditions: Hepatocellular Carcinoma
1 Location available
- Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC
Conditions: Hepatocellular Carcinoma
10 Locations available
- A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Patients With Hepa
Conditions: Hepatocellular Carcinoma
19 Locations available
- Yttrium-90 Radioembolization With Glass Microspheres (TheraSphere) for Patients With Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma
1 Location available
- HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer
Conditions: Hepatocellular Carcinoma
3 Locations available
- A Study of RO5137382 (GC33) in Patients With Advanced or Metastatic Hepatocellular Carcinoma
Conditions: Liver Cancer
2 Locations available
- A Study of Changes in Hepatic Function During Radiation Therapy Using Hepatobiliary Single Photon Emission Tomography (SPECT)
Conditions: Hepatocellular Carcinoma
1 Location available
- Dose Escalation Study for Primary Hepatocellular Carcinoma
Conditions: Carcinoma, Hepatocellular
1 Location available
- Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
Conditions: Hepatocellular Carcinoma
6 Locations available
- A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere®
Conditions: Liver Tumors - Hepatocellular Carcinoma - Hepatoma - Neoplasms
1 Location available
- Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)
Conditions: Hepatocellular Carcinoma
1 Location available
- Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma
12 Locations available
- E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Patients With Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma
5 Locations available
- Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma
Conditions: Carcinoma, Hepatocellular
1 Location available
- MEDI-573 in Combination With SOC in Unresectable or Metastatic HCC.
Conditions: Unresectable or Metastatic Hepatocellular Carcinoma (HCC)
5 Locations available
|